Biocon
Biocon, Sandoz ink global pact for immunology, oncology biosimilar
19 Jan 2018
Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally
Biocon Q1 net profit drops 51.2% to Rs81.3 crore
28 Jul 2017
.webp)
.webp)
